The only preclinical imaging platform allowing for fast in vivo screening of SPECT and alpha-emitting isotope radiopharmaceuticals

Features

  • Small animal, SPECT and alpha-emitting isotope live imaging platform
  • Real time, whole body imaging since time zero post injection
  • Fast screening of radiolabeled compounds
  • User interchangeable collimators for optimizing parameters on a wide range of applications
  • Compatible with 3rd party anesthesia and Vital Signs monitoring system
  • Extended version available, for up to 4 mice or 1 rat imaging

Performance

  • State-of-the-art detector characteristics
  • <2mm spatial resolution
  • Down to 10 sec frames for whole body scans
  • Energy resolution down to 19%
  • Detectable energy range 35-500 keV
  • Weight less than 50kg
  • Dimensions: 43cm (L) x 46cm (W) x 43cm (H)

Definition of a user friendly platform

  • Straightforward workflow with easy imaging protocol set-up
  • Plain to operate by non highly-experienced professionals
  • Footprint allowing for simple system installation and transfer
  • Ideal for imaging inside a clean room, or next to a cyclotron
  • Visual | eyesTM  software hub for post processing of imaging data

    Applications

    Oncology, Alpha Emitters

    [225]Ac imaging using γ-eye™

    In vivo imaging of alpha-emitting isotopes made possible, with BIOEMTECH technology. Two illustrative images, from two timepoints: 2h and 24h post injection with a Ac-225 radiopharmaceutical, in an oncology model. Scan duration 10 min. Dose injected: 3.5 uCi / 0.13 Mbq. Images acquired at Radiomedix laboratories.

    Looking for more info on the γ-eye™ and its applications?

    Download the γ-eye™ Brochure

    γ-eye™ Brochure | PDF

    Download